Cargando…
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
Parkinson's disease (PD) shows high heterogeneity with regard to the underlying molecular pathogenesis involving multiple pathways and mechanisms. Diagnosis is still challenging and rests entirely on clinical features. Thus, there is an urgent need for robust diagnostic biofluid markers. Untarg...
Autores principales: | Stoessel, Daniel, Schulte, Claudia, Teixeira dos Santos, Marcia C., Scheller, Dieter, Rebollo-Mesa, Irene, Deuschle, Christian, Walther, Dirk, Schauer, Nicolas, Berg, Daniela, Nogueira da Costa, Andre, Maetzler, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844983/ https://www.ncbi.nlm.nih.gov/pubmed/29556190 http://dx.doi.org/10.3389/fnagi.2018.00051 |
Ejemplares similares
-
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
por: T. dos Santos, Marcia Cristina, et al.
Publicado: (2018) -
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease
por: dos Santos, Marcia Cristina T., et al.
Publicado: (2018) -
Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
por: Stoessel, Daniel, et al.
Publicado: (2018) -
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
por: Heinzel, Sebastian, et al.
Publicado: (2014) -
Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls
por: Maetzler, Walter, et al.
Publicado: (2014)